Maximilian von Eynatten currently serves as the Head of Development at Grünenthal Group, a position held since October 2025. Prior to this role, Maximilian was the Head of Global Clinical Science at Aimmune Therapeutics from October 2020 to October 2025 and held the title of Head Global Clinical Development at Nestlé Health Science from July 2019 to October 2025. Maximilian also served as Global Head of Medical Affairs for the Cardio-Metabolism therapeutic area at Boehringer Ingelheim from June 2009 to June 2019 and was a Faculty and Clinical Researcher in the Department of Medicine at the Technical University of Munich from October 2006 to May 2009.
This person is not in any teams
This person is not in any offices